source
- ARPA-H launches SPECTRA program to advance autism diagnosis and precision careARPA-H announced the launch of the Systems for Phenotypic Evaluation, Clinical Trajectories, Response, and Agency (SPECTRA) program, a new effort aimed at transforming autism diagnosis and precisio…
- Lisata Therapeutics merges with Marea Therapeutics in reverse merger after failed Kuva dealLisata Therapeutics, a solid tumor biotech, announced a stock-for-stock merger with cardiovascular specialist Marea Therapeutics after a previous merger attempt with Kuva Labs collapsed. The trans…